Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

26
Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO Omixon Workshops Considerations for Analyzing Targeted NGS Data - Exome Tim Hague, CEO

Transcript of Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Page 1: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Considerations for Analyzing Targeted NGS Data

Exome

Tim Hague, CTO

Omixon WorkshopsConsiderations for Analyzing Targeted NGS Data - ExomeTim Hague, CEO

Page 2: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.
Page 3: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

3 sets of full exome sequences for the same individual, targeted by 3 different kits

One set had data problems because reads were from 2 different sequencers

Remaining 2 sets were analyzed both by the customer and by Omixon

Exome Analysis

Page 4: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Illumina TruSeq ~62 Mbp

Nimblegen SeqCap EZ Exome ~64 Mbp

~35 Mbp overlap between targets

Exons, ORFs and putative translated regions captured

40M and 37M read pairs resp., 101bp length

Exome Targets

Page 5: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

In this case we are comparing two full NGS analysis pipelines

Including the mapping/alignment and a multi-step variant call pipeline

The Omixon pipeline for this analysis uses two variant callers

The Omixon pipeline also uses recalibration and indel realignment

Full Analysis Pipelines

Page 6: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Finding Long Indels 1.

Page 7: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Better Indel Resolution 1.

Page 8: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Better Indel Resolution 2.

Page 9: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

If indels are important to an analysis then this needs to be taken into account, from the planning stage onwards

BWA does better when indel realignment is used, in combination with paired data

Indel Handling

Page 10: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Less Low Quality False Positives

Page 11: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Some of these low quality variants can be removed by filtering, after variant call

Quality and coverage cut-offs have to be parameterized properly in the alignment and variant call

Quality recalibration can also help to reduce low quality false positives

Quality and Coverage

Page 12: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Variations Next to Coding Areas

Page 13: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Most of the exon kits also provide variant calls close to the coding regions

These should be included in the analysis if possible

Splicing and Promoters

Page 14: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Less False Positives in Complex Regions 1.

Page 15: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Less False Positives in Complex Regions 2.

Page 16: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Less False Positives in Complex Regions 3.

Page 17: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Less False Positives in Complex Regions 4.Higher Coverage

Page 18: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Less False Positives in Complex Regions 5.Lower Coverage

Page 19: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Mismappings due to pseudogenes or repeats – or just complex regions?

Sometime more coverage can actually be bad

Need to watch out for non-specific read mappings (reads mapping to multiple places)

Complex Regions

Page 20: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Regions Where Both Aligners are Confused 1.

Page 21: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Regions Where Both Aligners are Confused 2.

Page 22: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Some regions are extremely difficult to map with any techniques

A different approach may be required to mapping/alignment

A different approach may be required to variant call (local de novo, phasing etc)

Very Complex Regions

Page 23: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Problems with Sex Chromosomes

There are may heterozygous calls in the X and Y chromosomes that are certainly false positives or incorrect calls.

This is true for both pipelines, the read specificity and variant call procedure has to be improved for these chromosomes.

Page 24: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

These kinds of comparative studies can be useful in analyzing the effectiveness of exome sequencing

Different exome kits can give different results

The data analysis and variant call tools chosen for the analysis can also have a big impact

There is some potential to improve the quality of the customer's exome analysis pipeline

Summary

Page 25: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Contact

Tim Hague, CEO

Omixon Biocomputing Solutions

[email protected]

+36 70 318 4878

Page 26: Considerations for Analyzing Targeted NGS Data Exome Tim Hague, CTO.

Download our Omixon Target™ Evaluation Version

Today

OMIXON.COM